AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Nano TransMed Article
PDF (1.3 MB)
Cite
EndNote(RIS) BibTeX
Collect
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Highlight | Open Access

On nano-solutions to overcome cancer hypoxia and resistance

Department of Physics, The University of Texas at Arlington, Arlington, Texas 76019-0059, USA
Show Author Information

Abstract

Cancer is a leading cause of death globally, and current cancer therapies often fall short in reducing death and improving quality of life. Early detection of cancer cells and targeted drug application is crucial to optimal treatment. Nanotechnology shows promise in improving cancer diagnosis and treatment by reducing toxicity and refractory disease. In this essay, we focus on how nanotechnology can overcome resistance and hypoxic issues in cancer treatment.

References

【1】
【1】
 
 
Crossref Google Scholar
Nano TransMed
Volume 2 Issue 1,
March 2023
Article number: e9130020
DOI: 10.26599/NTM.2023.9130020

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Chen W. On nano-solutions to overcome cancer hypoxia and resistance. Nano TransMed, 2023, 2(1): e9130020. https://doi.org/10.26599/NTM.2023.9130020

2205

Views

250

Downloads

12

Crossref
Received: 26 March 2023
Accepted: 29 March 2023
Published: 03 April 2023
© The Author(s) 2023. Nano TransMed published by Tsinghua University Press.

The articles published in this open access journal are distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.